Evidence map›Paper›PMID 35706429›Full record

ArticleJournal of applied statistics2021

Augmented-limited regression models with an application to the study of the risk perceived using continuous scales.

Ana R S Silva, Caio L N Azevedo, Jorge L Bazán, Juvêncio S Nobre

Abstract read
In one paragraph

Article in Journal of applied statistics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana R S SilvaDepartment of Statistics, State University of Campinas, Campinas, Brazil.
Caio L N AzevedoDepartment of Statistics, State University of Campinas, Campinas, Brazil.
Jorge L BazánInstitute of Mathematical Science and Computing, University of São Paulo, São Paulo, Brazil.
Juvêncio S NobreDepartment of Statistics and Applied Mathematics, Federal University of Ceará, Ceará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of risk perceived using continuous scales of [0,100] were recently introduced in psychometrics, which can be transformed to the unit interval, but the presence of zeros or ones are commonly observed. Motivated by this, we introduce a full inferential set of tools that allows for augmented and limited data modeling. We considered parameter estimation, residual analysis, influence diagnostic and model selection for zero-and/or-one augmented beta rectangular (ZOABR) regression models and their particular nested models, which is based on a new parameterization of the beta rectangular distribution. Different from other alternatives, we performed maximum-likelihood estimation using a combination of the EM algorithm (for the continuous part) and Fisher scoring algorithm (for the discrete part). Also, we perform an additional step, by considering other link functions, besides the usual logistic link, for modeling the response mean. By considering randomized quantile residuals, (local) influence diagnostics and model selection tools, we identified that the ZOABR regression model is the best one. We also conducted extensive simulations studies, which indicate that all developed tools work properly. Finally, we discuss the use of this type of models to treat psychometric data. It is worthwhile to mention that applications of the developed methods go beyond to Psychometric data. Indeed, they can be useful when the response variable in bounded, including or not the respective limits.

Indexed as

Augmented beta rectangular distributiondiagnostic analysisfrequentist inferencelimited responseregression models

Identifiers

PMID35706429
PMCPMC9041934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.